Jeffrey W. Clark, MD, Ph.D. Boston, USA
Editorial Board
Jeffrey W. Clark, Associate Professor, Medicine, Harvard Medical School, Director of the Clinical Trials Core, Dana-Farber/Partners Cancer Care, Medical Director, Cancer Center Protocol Office, Massachussetts General Hospital.
The major area of his research focus is in the evaluation of new agents and approaches in phase I, pilot and early phase II trials. This includes the evaluation of pharmacokinetics and biological correlates of the activity of these agents or approaches. He is also especially interested in the development of new theraputic approaches for gastrointestestional malignancies.